| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 03/28/2013 | US20130079301 Hypertonic dextran solution and methods of treating and preventing recurrent corneal erosion |
| 03/28/2013 | CA2858033A1 Quinolyl-containing hydroxamic acid compound and preparation method thereof, and pharmaceutical composition containing this compound and use thereof |
| 03/28/2013 | CA2849366A1 Compositions and methods for treating presbyopia, mild hyperopia, and irregular astigmatism |
| 03/27/2013 | EP2571531A2 Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN103002923A Stabilized fibronectin domain compositions, methods and uses |
| 03/27/2013 | CN103002920A Modified binding proteins inhibiting the VEGF-A receptor interaction |
| 03/27/2013 | CN103002904A Anti-angiogenic agent and method of using such agent |
| 03/27/2013 | CN103002884A Intraocular pressure reduction with intracameral bimatoprost implants |
| 03/27/2013 | CN102994500A Methods for treating eye disorders |
| 03/27/2013 | CN102989038A Preparation method and application of collagen-based composite corneal substitute capable of delivering endothelial inhibitory hormone |
| 03/27/2013 | CN102988965A Use of ubiquitin-proteasome system in preparation of anti-lenticular opacity products |
| 03/27/2013 | CN102988926A Tri-jiao heat-clearing tablet |
| 03/27/2013 | CN102988908A Wine for glaucoma and astigmatism |
| 03/27/2013 | CN102988878A Chinese medicinal composition capable of clearing liver and improving vision and preparation method thereof |
| 03/27/2013 | CN102988732A Traditional Chinese medicine prescription for improving eyesight |
| 03/27/2013 | CN102988709A Method for preparing chrysanthemum and Cassia tora pills used for treating nearsightedness |
| 03/27/2013 | CN102988597A Cortex moutan radicis stomach-clearing and blood-cooling tablet |
| 03/27/2013 | CN102988513A Chinese medicinal composition with functions of removing nebula and improving vision, clearing heat and purging pathogenic fire |
| 03/27/2013 | CN102988336A Use of TPCK (N-tosyl-L-phenylanyl chloromethyl ketone) in preparation of anti-lenticular opacity products |
| 03/27/2013 | CN102988331A Use of 2-mercapto-3-butanol in preparation of anti-lenticular opacity products |
| 03/27/2013 | CN102988301A Preparation method of long-acting sustained-release microspheres containing bevacizumab |
| 03/27/2013 | CN102988289A Preparation method for fat-soluble phtosensitizer nanoparticles and application thereof |
| 03/27/2013 | CN102988280A Garenoxacin eye drops |
| 03/27/2013 | CN102988278A Bromfenac sodium hydrate eye drops and preparation method thereof |
| 03/27/2013 | CN102114044B Artificially processed bear bile powder and preparation method thereof |
| 03/27/2013 | CN102046173B Aqueous liquid containing gatifloxacin, method for production thereof, and method for prevention of production of precipitates during storage of the aqueous liquid at low temperature or upon freezing/thawing of the aqueous liquid |
| 03/27/2013 | CN101921772B Human antibodies that bind human IL-12 and methods for producing |
| 03/27/2013 | CN101829199B Application of ranunculus japonicus extract in preparing anti-tumor and anti-tumor angiogenesis drugs |
| 03/27/2013 | CN101066997B Human antibodies that bind human IL-12 and methods for producing |
| 03/26/2013 | US8404737 Substituted isoindoline-1,3-dione derivatives |
| 03/26/2013 | US8404715 Methods and compositions using racemic, (R)-, and (S)-fexofenadine in combination with leukotriene inhibitors |
| 03/26/2013 | US8404676 Oxadiazole diaryl compounds |
| 03/26/2013 | US8404265 Contact lenses for extended release of bioactive agents containing diffusion attenuators |
| 03/26/2013 | US8404250 Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation |
| 03/26/2013 | US8404231 Lysyl oxidase-like 1 (LOXL1) and elastogenesis |
| 03/26/2013 | US8404226 Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
| 03/26/2013 | CA2565295C Steroid intraocular implants having an extended sustained release for a period of greater than 2 months |
| 03/26/2013 | CA2537820C Process for preparing water-soluble medicaments comprising complexation of forskolin in cyclodextrins |
| 03/21/2013 | WO2013039140A1 Fused heterocyclic derivative |
| 03/21/2013 | WO2013038195A2 Pharmaceutical nanoparticle compositions |
| 03/21/2013 | WO2013037794A1 Use of omega fatty acids for treating disease |
| 03/21/2013 | WO2013037479A1 Ophthtalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid |
| 03/21/2013 | WO2012162257A3 Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers |
| 03/21/2013 | US20130072568 Retinoid replacements and opsin agonists and methods for the use thereof |
| 03/21/2013 | US20130072567 Treatment of faecal incontinence and other conditions with 1r, 2s-methoxamine |
| 03/21/2013 | US20130072546 Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra |
| 03/21/2013 | US20130072522 Process for Making Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 03/21/2013 | US20130072481 mTOR SELECTIVE KINASE INHIBITORS |
| 03/21/2013 | US20130072470 Novel tricyclic compounds |
| 03/21/2013 | US20130072432 Ptd-uqcrb fusion polypeptide, and pharmaceutical composition for preventing and treating ischemic diseases, containing same |
| 03/21/2013 | US20130072425 Saposin-a derived peptides and uses thereof |
| 03/21/2013 | US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt) |
| 03/21/2013 | US20130071462 Drug Delivery Systems and Applications |
| 03/21/2013 | CA2848156A1 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid |
| 03/21/2013 | CA2845868A1 Use of omega fatty acids for treating disease |
| 03/21/2013 | CA2845673A1 Pharmaceutical nanoparticle compositions |
| 03/20/2013 | EP2570402A1 Bi-aryl derivatives, their preparation and their therapeutic application |
| 03/20/2013 | EP2570136A2 Protein A compositions and methods of use |
| 03/20/2013 | EP2569325A1 Method of reducing intraocular pressure in humans using n6 - cyclopentyladenosine (cpa), cpa derivatives or prodrugs thereof |
| 03/20/2013 | EP2568997A2 Compositions and methods which modulate g-protein signaling for the treatment of inflammatory disorders such as asthma and allergic conjunctivitis |
| 03/20/2013 | CN1606554B Beta-lactamyl vasopressin v1a antagonists |
| 03/20/2013 | CN1441841B Stimulation of cellular regeneration and differentiation in inner ear |
| 03/20/2013 | CN102985084A Compounds for the treatment of posterior segment disorders and diseases |
| 03/20/2013 | CN102985083A Formulations of quinones for the treatment of ophthalmic diseases |
| 03/20/2013 | CN102978079A Coffee senna health-care liquor for treating liver heat and red eye |
| 03/20/2013 | CN102977212A Compositions comprising anti-IGF-1r antibodies and methods for their production |
| 03/20/2013 | CN102977048A Substituted cyclopentanes having prostaglandin activity |
| 03/20/2013 | CN102976937A Retinal derivatives and methods for the use thereof for the treatment of visual disorders |
| 03/20/2013 | CN102973909A Tablets with functions of yang warming, diuresis inducing and kidney reinforcing |
| 03/20/2013 | CN102973842A Traditional Chinese medicine fuming and washing liquid for treating xerophthalmia |
| 03/20/2013 | CN102973775A Medicine for treating cataract |
| 03/20/2013 | CN102973754A Traditional Chinese medicine composition for effectively treating chalazion disease |
| 03/20/2013 | CN102973748A Chinese patent medicine granules for treating eyeground macular edema |
| 03/20/2013 | CN102973745A Traditional Chinese medicine composition for treating central retinitis and preparation method thereof |
| 03/20/2013 | CN102973743A Clear vision capsule |
| 03/20/2013 | CN102973689A High effect suppurative otitis powder and preparation method thereof |
| 03/20/2013 | CN102973594A Ophthalmic preparation containing oxygen micro-capsules and preparation method |
| 03/20/2013 | CN102441001B Compound allantoin vitamin B6-E and ammoniation ethyl sulfate eye drops and preparation method thereof |
| 03/20/2013 | CN101959519B Low viscosity, highly flocculated triamcinolone acetonide suspensions for intravitreal injection |
| 03/20/2013 | CN101888839B Omega-3 fatty acids, hydroxy polyunsaturated fatty acids, lipoxin compounds, or oxylipin compounds for the treatment of ophthalmic conditions |
| 03/20/2013 | CN101785789B Method for preparing animal gall powder |
| 03/20/2013 | CN101674807B Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
| 03/19/2013 | US8398998 Therapeutic composition comprising a botulinum neurotoxin |
| 03/19/2013 | CA2706872C Intermediates for the preparation of lipoxin a4 analogs |
| 03/14/2013 | WO2013036105A1 Antisense oligonucleotides for the treatment of leber congenital amaurosis |
| 03/14/2013 | WO2013035861A1 Method for determining susceptibility to age-related macular degeneration, primer pair, probe, age-related macular degeneration diagnostic kit, therapeutic agent for age-related macular degeneration, and screening method for therapeutic agent for age-related macular degeneration |
| 03/14/2013 | WO2013035837A1 Method for suppressing decrease in viscosity of aqueous liquid agent |
| 03/14/2013 | US20130066058 Use of Antisense Oligonucleotides or siRNA to Suppress Expression of eIF-5A1 |
| 03/14/2013 | US20130065954 Ophthalmic uses of s1p receptor modulators |
| 03/14/2013 | US20130065909 Fatty acid fumarate derivatives and their uses |
| 03/14/2013 | US20130065899 Heteroaryl compounds and uses thereof |
| 03/14/2013 | US20130065894 6-(4-HYDROXY-PHENYL)-3-STYRYL-1H-PYRAZOLO[3,4-b]PYRIDINE-4-CARBOXYLIC ACID AMIDE DERIVATIVES AS KINASE INHIBITORS |
| 03/14/2013 | US20130065890 Pyrimidine derivatives |
| 03/14/2013 | US20130065888 Ophthalmic formulations and processes for their preparation |
| 03/14/2013 | US20130065883 Triazolo [4, 5- B] Pyridin Derivatives |
| 03/14/2013 | US20130065880 Compounds as tyrosine kinase modulators |
| 03/14/2013 | US20130065869 Ophthalmologic irrigation solutions and method |
| 03/14/2013 | US20130065860 3-(4-(5-phenyl-1 ,2,4-oxadiazol-3-yl)phenoxy)propan-2-ol derivatives as sphingosine-1 phosphate receptors modulators |
| 03/14/2013 | US20130065818 Arylamide Compounds And Compositions And Uses Thereof |
| 03/14/2013 | US20130065816 Analogs of pituitary adenylate cyclase-activating polypeptide (pacap) and methods for their use |